Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering

D. C. Ardila, E. Tamimi, Thomas C Doetschman, W. R. Wagner, Jonathan P Vande Geest

Research output: Contribution to journalArticle

Abstract

Tissue engineering has gained considerable attention in the development of small diameter tissue engineered vascular grafts (TEVGs) for treating coronary heart disease. A properly designed acellular and biodegradable TEVG must encourage the infiltration and growth of vascular smooth muscle cells (SMCs). Our group has previously shown that increasing levels of TGFβ2 can differentially modulate SMC migration and proliferation. In this study, tubular electrospun scaffolds loaded with TGFβ2 were fabricated using various ratios of gelatin/polycaprolactone (PCL), resulting in scaffolds with porous nano-woven architecture suitable for tissue ingrowth. Scaffold morphology, degradation rate, TGβ2 release kinetics, and bioactivity were assessed. TGFβ2 was successfully integrated into the electrospun biomaterial that resulted in a differential release profile depending on the gelatin/PCL ratio over the course of 42 days. Higher TGFβ2 elution was obtained in scaffolds with higher gelatin content, which may be related to the biodegradation of gelatin in culture media. The biological activity of the released TGFβ2 was evaluated by its ability to affect SMC proliferation as a function of its concentration. SMCs seeded on TGFβ2-loaded scaffolds also showed higher densities and infiltration after 5 days in culture as compared to scaffolds without TGFβ2. Our results demonstrate that the ratio of synthetic and natural polymers in electrospun blends can be used to tune the release of TGFβ2. This method can be used to intelligently modulate the SMC response in gelatin/PCL scaffolds making the TGFβ2-loaded conduits attractive for cardiovascular tissue engineering applications.

Original languageEnglish (US)
Pages (from-to)44-52
Number of pages9
JournalJournal of Controlled Release
Volume299
DOIs
StatePublished - Apr 10 2019

Fingerprint

Gelatin
Tissue Engineering
Smooth Muscle Myocytes
Blood Vessels
Blood Vessel Prosthesis
Cell Proliferation
Biocompatible Materials
Vascular Smooth Muscle
Cell Movement
Coronary Disease
Culture Media
Polymers
Growth
polycaprolactone

Keywords

  • Electrospinning
  • Gelatin
  • Polycaprolactone
  • Smooth muscle cells
  • TGFβ2 release
  • Vascular tissue engineering

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering. / Ardila, D. C.; Tamimi, E.; Doetschman, Thomas C; Wagner, W. R.; Vande Geest, Jonathan P.

In: Journal of Controlled Release, Vol. 299, 10.04.2019, p. 44-52.

Research output: Contribution to journalArticle

@article{b3541e1ea9554b0ca63401cc07b5fc47,
title = "Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering",
abstract = "Tissue engineering has gained considerable attention in the development of small diameter tissue engineered vascular grafts (TEVGs) for treating coronary heart disease. A properly designed acellular and biodegradable TEVG must encourage the infiltration and growth of vascular smooth muscle cells (SMCs). Our group has previously shown that increasing levels of TGFβ2 can differentially modulate SMC migration and proliferation. In this study, tubular electrospun scaffolds loaded with TGFβ2 were fabricated using various ratios of gelatin/polycaprolactone (PCL), resulting in scaffolds with porous nano-woven architecture suitable for tissue ingrowth. Scaffold morphology, degradation rate, TGβ2 release kinetics, and bioactivity were assessed. TGFβ2 was successfully integrated into the electrospun biomaterial that resulted in a differential release profile depending on the gelatin/PCL ratio over the course of 42 days. Higher TGFβ2 elution was obtained in scaffolds with higher gelatin content, which may be related to the biodegradation of gelatin in culture media. The biological activity of the released TGFβ2 was evaluated by its ability to affect SMC proliferation as a function of its concentration. SMCs seeded on TGFβ2-loaded scaffolds also showed higher densities and infiltration after 5 days in culture as compared to scaffolds without TGFβ2. Our results demonstrate that the ratio of synthetic and natural polymers in electrospun blends can be used to tune the release of TGFβ2. This method can be used to intelligently modulate the SMC response in gelatin/PCL scaffolds making the TGFβ2-loaded conduits attractive for cardiovascular tissue engineering applications.",
keywords = "Electrospinning, Gelatin, Polycaprolactone, Smooth muscle cells, TGFβ2 release, Vascular tissue engineering",
author = "Ardila, {D. C.} and E. Tamimi and Doetschman, {Thomas C} and Wagner, {W. R.} and {Vande Geest}, {Jonathan P}",
year = "2019",
month = "4",
day = "10",
doi = "10.1016/j.jconrel.2019.02.024",
language = "English (US)",
volume = "299",
pages = "44--52",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Modulating smooth muscle cell response by the release of TGFβ2 from tubular scaffolds for vascular tissue engineering

AU - Ardila, D. C.

AU - Tamimi, E.

AU - Doetschman, Thomas C

AU - Wagner, W. R.

AU - Vande Geest, Jonathan P

PY - 2019/4/10

Y1 - 2019/4/10

N2 - Tissue engineering has gained considerable attention in the development of small diameter tissue engineered vascular grafts (TEVGs) for treating coronary heart disease. A properly designed acellular and biodegradable TEVG must encourage the infiltration and growth of vascular smooth muscle cells (SMCs). Our group has previously shown that increasing levels of TGFβ2 can differentially modulate SMC migration and proliferation. In this study, tubular electrospun scaffolds loaded with TGFβ2 were fabricated using various ratios of gelatin/polycaprolactone (PCL), resulting in scaffolds with porous nano-woven architecture suitable for tissue ingrowth. Scaffold morphology, degradation rate, TGβ2 release kinetics, and bioactivity were assessed. TGFβ2 was successfully integrated into the electrospun biomaterial that resulted in a differential release profile depending on the gelatin/PCL ratio over the course of 42 days. Higher TGFβ2 elution was obtained in scaffolds with higher gelatin content, which may be related to the biodegradation of gelatin in culture media. The biological activity of the released TGFβ2 was evaluated by its ability to affect SMC proliferation as a function of its concentration. SMCs seeded on TGFβ2-loaded scaffolds also showed higher densities and infiltration after 5 days in culture as compared to scaffolds without TGFβ2. Our results demonstrate that the ratio of synthetic and natural polymers in electrospun blends can be used to tune the release of TGFβ2. This method can be used to intelligently modulate the SMC response in gelatin/PCL scaffolds making the TGFβ2-loaded conduits attractive for cardiovascular tissue engineering applications.

AB - Tissue engineering has gained considerable attention in the development of small diameter tissue engineered vascular grafts (TEVGs) for treating coronary heart disease. A properly designed acellular and biodegradable TEVG must encourage the infiltration and growth of vascular smooth muscle cells (SMCs). Our group has previously shown that increasing levels of TGFβ2 can differentially modulate SMC migration and proliferation. In this study, tubular electrospun scaffolds loaded with TGFβ2 were fabricated using various ratios of gelatin/polycaprolactone (PCL), resulting in scaffolds with porous nano-woven architecture suitable for tissue ingrowth. Scaffold morphology, degradation rate, TGβ2 release kinetics, and bioactivity were assessed. TGFβ2 was successfully integrated into the electrospun biomaterial that resulted in a differential release profile depending on the gelatin/PCL ratio over the course of 42 days. Higher TGFβ2 elution was obtained in scaffolds with higher gelatin content, which may be related to the biodegradation of gelatin in culture media. The biological activity of the released TGFβ2 was evaluated by its ability to affect SMC proliferation as a function of its concentration. SMCs seeded on TGFβ2-loaded scaffolds also showed higher densities and infiltration after 5 days in culture as compared to scaffolds without TGFβ2. Our results demonstrate that the ratio of synthetic and natural polymers in electrospun blends can be used to tune the release of TGFβ2. This method can be used to intelligently modulate the SMC response in gelatin/PCL scaffolds making the TGFβ2-loaded conduits attractive for cardiovascular tissue engineering applications.

KW - Electrospinning

KW - Gelatin

KW - Polycaprolactone

KW - Smooth muscle cells

KW - TGFβ2 release

KW - Vascular tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85062031464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062031464&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2019.02.024

DO - 10.1016/j.jconrel.2019.02.024

M3 - Article

C2 - 30797003

AN - SCOPUS:85062031464

VL - 299

SP - 44

EP - 52

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -